InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the full record of transactions filed by Dunlop A. Sinclair, Director. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 13 disclosures have been logged. Total volume traded: €6.1m. The latest transaction was filed on 27 June 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
161,567 shares
Common Stock
SEC:0001193125-26-224633·
161,567 shares
Common Stock
SEC:0001193125-26-224633:0·
€59,2981,341 shares@ €44.21940.0011% mcap0.9% of flow
Common Stock
SEC:0000899243-22-024511:0·
€641,62815,000 shares@ €42.77520.012% mcap9.8% of flow
Common Stock
SEC:0000899243-22-024057:0·
€258,41820,000 shares@ €12.92090.0049% mcap3.9% of flow
Common Stock
SEC:0001127602-22-012483:0·
04,230 shares0
Common Stock
SEC:0001127602-22-000489·
04,230 shares0
Common Stock
SEC:0001127602-22-000489:0·
€81,6146,894 shares@ €11.83840.0016% mcap2.9% of flow
Common Stock
SEC:0001127602-21-025208·
€81,6146,894 shares@ €11.83840.0016% mcap1.2% of flow
Common Stock
SEC:0001127602-21-025208:0·
031,855 shares0
Common Stock
SEC:0000899243-21-021552·
031,855 shares0
Common Stock
SEC:0000899243-21-021552:0·
€3m64,179 shares@ €42.26110.052% mcap97.1% of flow
Common Stock
SEC:0000899243-21-020171·
€3m64,179 shares@ €42.26110.052% mcap41.4% of flow
Common Stock
SEC:0000899243-21-020171:0·
13 of 13 declarations
About Dunlop A. Sinclair
Dunlop A. Sinclair is a director at Apellis Pharmaceuticals, Inc.
